• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: New insider Bank Of America Corp /De/ claimed ownership of 234,056 shares (SEC Form 3)

    2/5/26 8:48:13 AM ET
    $FEED
    Industrial Specialties
    Health Care
    Get the next $FEED alert in real time by email
    SEC FORM 3/A SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    BANK OF AMERICA CORP /DE/

    (Last) (First) (Middle)
    BANK OF AMERICA CORPORATE CENTER
    100 N TRYON ST

    (Street)
    CHARLOTTE NC 28255

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    01/30/2026
    3. Issuer Name and Ticker or Trading Symbol
    ENvue Medical, Inc. [ FEED ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    02/04/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 234,056(1) I See Footnotes(1)(2)(3)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    BANK OF AMERICA CORP /DE/

    (Last) (First) (Middle)
    BANK OF AMERICA CORPORATE CENTER
    100 N TRYON ST

    (Street)
    CHARLOTTE NC 28255

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    BOFA SECURITIES, INC.

    (Last) (First) (Middle)
    150 N COLLEGE ST
    NC1-028-29-04

    (Street)
    CHARLOTTE NC 28255

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    BANK OF AMERICA NA

    (Last) (First) (Middle)
    100 NORTH TRYON STREET

    (Street)
    CHARLOTTE NC 28255

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. The determination of 10% Owner relies on the 1,088,192 outstanding shares disclosed in the Form 424B3 - Prospectus by the issuer on December 18, 2025, which reports share totals as of December 5, 2025. The prospectus pertains to the resale, from time to time, by selling stockholders of up to 7,962,279 shares of common stock. While not yet finalized, the issuance of additional shares could materially increase the number of outstanding common shares and result in substantial dilution to existing stockholders.
    2. This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I ("the Securities") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS.
    3. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
    Remarks:
    This Amendment to Form 3 supersedes and replaces the original Form 3 filed on February 4, 2026 to correct and update the information previously reported with respect to Date of Event Requiring Statement (Month/Day/Year).
    BANK OF AMERICA CORP/DE/ By: Its: Authorized Signatory /s/ Andres Ortiz 02/05/2026
    BOFA SECURITIES, INC. By: Its: Authorized Signatory /s/ Andres Ortiz 02/05/2026
    BANK OF AMERICA NA By: Its: Authorized Signatory /s/ Andres Ortiz 02/05/2026
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $FEED alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FEED

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FEED
    SEC Filings

    View All

    SEC Form EFFECT filed by ENvue Medical Inc.

    EFFECT - ENvue Medical, Inc. (0001326706) (Filer)

    5/29/26 12:15:25 AM ET
    $FEED
    Industrial Specialties
    Health Care

    SEC Form 424B3 filed by ENvue Medical Inc.

    424B3 - ENvue Medical, Inc. (0001326706) (Filer)

    5/28/26 4:15:20 PM ET
    $FEED
    Industrial Specialties
    Health Care

    SEC Form S-3 filed by ENvue Medical Inc.

    S-3 - ENvue Medical, Inc. (0001326706) (Filer)

    5/18/26 5:17:30 PM ET
    $FEED
    Industrial Specialties
    Health Care

    $FEED
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network

    TYLER, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical," or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that a major U.S. academic health network has expanded its use of the ENvue™ Navigation Platform into its American Burn Association-verified burn intensive care unit, marking the second deployment within the same health system and expanding access to ENvue's technology for a particularly vulnerable patient population. "We believe that this health network's decision to bring the ENvue Navigation Platform into their burn ICU speaks directly to the clinica

    6/5/26 9:00:00 AM ET
    $FEED
    Industrial Specialties
    Health Care

    ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System

    Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction in Over 350 Nursing Hours in Year One, and 20% Decrease in Repeat Imaging Validates Value of Integrating ENvue Navigation Platform as Standard of Care in U.S. Hospitals, Saving Costs on Nursing Hours, Imaging, and Patient Complications Findings Published in Official Journal of the American Association of Critical Care Nurses TYLER, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that an independent, peer-reviewed study has

    6/3/26 8:17:00 AM ET
    $FEED
    Industrial Specialties
    Health Care

    ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026

    TYLER, Texas, May 19, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that the Company will participate as an exhibitor at the American Association of Critical Care Nurses National Teaching Institute & Critical Care Exposition ("AACN NTI") 2026, taking place May 21–22, 2026. Recognized as the largest critical care nursing conference in the United States, AACN NTI brings together thousands of frontline nurses, nurse leaders, educators and healthcare professionals from leading hospitals and healthcare systems nationwide. "Cr

    5/19/26 9:00:00 AM ET
    $FEED
    Industrial Specialties
    Health Care

    $FEED
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glibert Christian Michael bought $640,800 worth of shares (240,000 units at $2.67) (SEC Form 4)

    4 - ENvue Medical, Inc. (0001326706) (Issuer)

    2/11/26 6:52:48 PM ET
    $FEED
    Industrial Specialties
    Health Care

    $FEED
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Glibert Christian Michael

    4 - ENvue Medical, Inc. (0001326706) (Issuer)

    4/17/26 5:10:54 PM ET
    $FEED
    Industrial Specialties
    Health Care

    SEC Form 3 filed by new insider Fernandez-Mcgovern Nicole M.

    3 - ENvue Medical, Inc. (0001326706) (Issuer)

    2/26/26 7:46:18 PM ET
    $FEED
    Industrial Specialties
    Health Care

    New insider Glibert Christian Michael claimed ownership of 240,000 shares (SEC Form 3)

    3 - ENvue Medical, Inc. (0001326706) (Issuer)

    2/11/26 7:00:21 PM ET
    $FEED
    Industrial Specialties
    Health Care

    $FEED
    Leadership Updates

    Live Leadership Updates

    View All

    ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

    TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue's U.S. commercialization strategy, with a focus on expanding its existing presence in 38 hospitals and accelerating revenue across the Company's enteral platform. "Marc is a highly accomplished sales leader with extensive GPO and IDN expertise and long-standing relationships th

    1/21/26 8:30:00 AM ET
    $FEED
    $NAOV
    Industrial Specialties
    Health Care

    ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

    ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced the appointment of David Johnson as Chairman of the Board. Mr. Johnson will work alongside CEO, Doron Besser, and the existing leadership team. David Johnson, newly appointed Chairman of ENvue, stated, "We believe ENvue is at the forefront of advanced feeding-tube placement technology, which has been validated in the market and extensively used in the clinic across 38 hospitals in the US. In my opinion, the Company's unique feeding tube placement system that utilizes advanced methods of navigation, integrated sensors and body mapping h

    12/15/25 9:00:00 AM ET
    $ENVB
    $FEED
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties